Press release
Kidney Cancer Diagnostics And Therapeutics Market Study Explores Industry Growth Toward $6.08 Billion
Kidney Cancer Diagnostics And Therapeutics Market
Forecasted Growth and Market Size of Kidney Cancer Diagnostics and Therapeutics
The kidney cancer diagnostics and therapeutics sector is projected to experience substantial growth, reaching a market value of $6.08 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 7.2%. Several factors contribute to this rise, including the increasing use of immunotherapy treatments, higher investments in oncology research, broader adoption of genomic testing for cancer management, and ongoing advancements in precision medicine. Additional drivers include better access to cutting-edge diagnostic tools. Key trends shaping this growth involve a stronger uptake of targeted therapies and immunotherapies, wider use of sophisticated imaging techniques for early detection, growing demand for personalized treatment plans, expansion of biomarker-driven diagnostics, and improved integration between diagnostic and therapeutic strategies.
The kidney cancer diagnostics and therapeutics market size has grown strongly in recent years. It will grow from $4.31 billion in 2025 to $4.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing incidence of renal cell carcinoma, advancement in imaging and biopsy techniques, established use of targeted therapies, growing awareness of early cancer diagnosis, expansion of oncology treatment centers.
Download a free sample of the kidney cancer diagnostics and therapeutics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11937&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Notable Industry Leaders in Kidney Cancer Diagnostics and Therapeutics
The competitive landscape of this market is dominated by prominent pharmaceutical and biotechnology firms such as Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Eisai Co., Ltd., Ipsen S.A., Exelixis Inc., Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Invitae Corporation, Bio-Rad Laboratories, Inc., and Laboratory Corporation of America Holdings.
In a significant development in May 2023, Australia-based Telix Pharmaceuticals Limited acquired the US biotechnology firm QSAM Biosciences, Inc. Although the financial details were undisclosed, this strategic move aims to bolster Telix's portfolio in targeted radiopharmaceuticals for cancer treatment. By leveraging QSAM's expertise and proprietary technologies, Telix intends to accelerate the development of innovative therapies and strengthen its position within the precision medicine segment.
Trends Propelling Innovation in Kidney Cancer Diagnostics and Therapeutics
Leading companies in this sector are focusing heavily on advancing treatments for renal cell carcinoma (RCC) to enhance patient outcomes and tailor therapies to individual needs. Research into RCC is crucial as it guides the development of novel diagnostic approaches and targeted therapies that enable earlier detection and personalized care.
For example, in December 2023, Merck introduced Welireg (belzutifan), the first approved hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor for adults with advanced RCC who have previously undergone treatment with PD-1 or PD-L1 inhibitors and VEGF-TKIs. This breakthrough therapy is associated with improved progression-free survival and higher response rates compared to the traditional drug everolimus. Welireg's approval marks a significant milestone in the kidney cancer diagnostics and therapeutics space, offering new hope for patients facing disease progression.
View the full kidney cancer diagnostics and therapeutics market report:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Segmentation Breakdown in the Kidney Cancer Diagnostics and Therapeutics Market
The kidney cancer diagnostics and therapeutics market is divided into several important segments:
1) By Cancer Type: Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma, and Transitional Cell Carcinoma
2) By Component: Drugs and Diagnostics
3) By Therapy: Targeted Therapy and Immunotherapy
4) By End-Users: Hospitals and Genomics Laboratories
Further subcategories provide detailed classifications such as:
- Clear Cell RCC by stages I through IV
- Papillary RCC divided into Type 1 and Type 2
- Chromophobe RCC as localized or advanced
- Urothelial Carcinoma and Transitional Cell Carcinoma categorized into non-muscle invasive, muscle invasive, and metastatic types
This detailed segmentation highlights the diverse range of treatment approaches and diagnostic strategies tailored to specific kidney cancer subtypes and patient needs.
Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Diagnostics And Therapeutics Market Study Explores Industry Growth Toward $6.08 Billion here
News-ID: 4608594 • Views: …
More Releases from The Business Research Company
Krabbe Disease Treatment Market Report Examines Industry Trends, Growth Drivers …
The treatment landscape for Krabbe disease is advancing rapidly, with significant growth anticipated in the coming years. Innovations in gene therapy, early diagnosis, and supportive care are shaping the future of this rare neurodegenerative disorder's management. Let's explore the market size projections, key players, emerging trends, and primary segments defining this critical healthcare sector.
Projected Expansion in the Krabbe Disease Treatment Market
The market for Krabbe disease treatments is poised…
Knee Braces Market Report Examines Leading Companies And Growth Opportunities
The knee braces market is on track for significant expansion in the coming years, driven by various healthcare and lifestyle factors. As more people seek effective solutions for joint support and injury prevention, this market is set to witness steady growth and evolving product innovations.
Projected Market Size and Growth Outlook for Knee Braces
By 2030, the knee braces market is expected to reach a value of $2.42 billion, growing…
Kidney Stone Management Market Outlook Highlights Strategic Opportunities Across …
The kidney stone management sector is on the verge of substantial expansion as medical technology and procedural advancements continue to evolve. Increasing adoption of minimally invasive techniques and enhanced diagnostic tools are set to transform how kidney stones are treated, promising better patient outcomes and streamlined clinical practices. Below is a detailed look at the market's size, key drivers, major players, trends, and segment-specific insights shaping this important healthcare arena.
Projected…
Ketamine Clinic Market Research Reveals Path To $2.07 Billion By 2030
The ketamine clinic sector is poised for impressive expansion as awareness and acceptance of ketamine-based treatments continue to rise. Innovations in therapy delivery and increasing mental health investments are setting the stage for significant market progress. The following overview explores the market size trajectory, key players, emerging trends, and segment breakdowns shaping this evolving industry.
Projected Growth and Size of the Ketamine Clinic Market
The ketamine clinic market is anticipated…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
